The experimental results emphasized the relevance of targeting P-selectin for the treatment of thrombosis with rtPA for the first time, which is of great significance for the subsequent development of nanoparticles with P-selectin as the target of thrombosis treatment. Here, SELP is linked to deep vein thrombosis.